EspaƱol
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 44 for your search:
Drug:  yttrium Y 90 ibritumomab tiuxetan
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: SHEBA-07-4466-AN-CTIL, NCT00491491

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 19 and over
Sponsor: Other
Protocol IDs: 535-00, CDR0000069211, NCI-V02-1691, UNMC-535-00, NCT00031642

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02721, AMC-037, U01CA070019, CDR0000310158, NCT00064246

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: ID01-233, NCT00048737

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 51 to 75
Sponsor: Other
Protocol IDs: CDR0000515982, KRDI-TUM-R-F-015-V-0030-I, EU-20633, NCT00397800

6.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: LS0382, 703-04, MAYO-LS0382, MAYO-IRB-703-04, NCT00438880

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2005-002206-37, NCT00302757

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 60
Sponsor: NCI, Other
Protocol IDs: 98153, P30CA033572, P01CA030206, CHNMC-98153, CDR0000574716, NCT00562978

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: NU 02H8, 1346001, NU-0228-024, PCI-P-PCYC-0213, NCT00089284

10.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: NU 05H9, STU00004871, NU-0522-060, MILLENNIUM-NU-05H9, NCT00372905

11.

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 60 and over
Sponsor: NCI, Other
Protocol IDs: 02-090, MSKCC-02090, NCT00058422

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000304498, CALGB-50201, SWOG-C50201, ECOG-C50201, NCT00062114

13.

Phase: Phase II
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000329864, U10CA032102, S0313, SWOG-S0313, NCT00070018

14.

Phase: Phase II
Type: Treatment
Status: Unknown
Age: 18 and over
Sponsor: Other
Protocol IDs: BIDMC-2003P-000182, NCT00073957

15.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: ID01-541, NCT00038623

16.

Phase: Phase II
Type: Treatment
Status: Unknown
Age: Over 18
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: BIDMC-2004P-000044, NCT00110149

17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 04-251, NCT00119730

18.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: Z-BEAM, NCT00138086

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: Ritux plus TNI, NCT00147953

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: SCRI LYM 27, 106-P092, NCT00193505

21.

Phase: Phase II
Type: Treatment
Status: Closed
Age: No age limit
Sponsor: Other
Protocol IDs: ID03-0287, NCI-2011-02453, NCT00290511

22.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 64 and under
Sponsor: Other
Protocol IDs: AMC 2005-276, NCT00336843

23.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: TH011101, NCT00440583

24.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005-0512, NCI-2012-01569, NCT00493467

25.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 65 to 80
Sponsor: Other
Protocol IDs: CDR0000589530, CALACASS-3RCHOPZ, INCA-RECF0624, EUDRACT-2006-006179-19, CALACASS-2006/27, 3 R CHOP Z, NCT00690560
1   
New Search